MGMT and glioblastoma: Moreover, at least in O6-methylguanine-DNA methyltransferase (MGMT)-deficient tumors, repeated TMZ treatments very likely lead to an accumulation of critical DNA damages that trigger cell death, which is supported by our studies on glioblastoma cells in vitro (6).